Allylbenzene
Bluelighter
- Joined
- Jul 25, 2025
- Messages
- 987
Tom Ray had twenty-five psychedelic drugs from Shulgin’s toolkit broadly assayed by the National Institute of Mental Health – Psychoactive Drug Screening Program.
By synthesizing the subjective experience and molecular affinity data, he has been able to realize the Shulgin’s vision of using their toolkit of drugs to advance our understanding of the relationships between the brain, the drugs, and the mind; and most importantly, our understanding of ourselves.
“I’m looking for tools that can be used for studying the mind, and other people then will use the tools in finding out the aspects of the mental process and how it ties to the brain.”
– Sasha 1996
Full video presentation here (from Transform Press)
transformpress.com
By synthesizing the subjective experience and molecular affinity data, he has been able to realize the Shulgin’s vision of using their toolkit of drugs to advance our understanding of the relationships between the brain, the drugs, and the mind; and most importantly, our understanding of ourselves.
“I’m looking for tools that can be used for studying the mind, and other people then will use the tools in finding out the aspects of the mental process and how it ties to the brain.”
– Sasha 1996
Sasha was onto something big. I believe that the greatest scientific value of Sasha’s work is that he has left behind a diverse toolkit of probes into the human mind, that allow the unlocking of many of its secrets. Sasha has provided us with a methodology for mental discovery. I don’t believe that there is any other method that can make as deep a penetration into the structure, function, process, genetics, development, and evolution of the human mind, and mechanisms of consciousness. We can put this knowledge to work not just in providing newapproaches to understanding the etiology, diagnosing, treating, and healing mental disorders; but also in understanding ourselves. We owe these discoveries to the foundations that Sasha has laid.
In choosing the drugs for this study, I have included drugs to represent both structural and qualitative diversity. I drew up a list of twenty-five drugs in consultation with Alexander Shulgin, Ann Shulgin, and Dave Nichols.
Full video presentation here (from Transform Press)
Breadth and Depth - TransformPress
Tom Ray builds on the work of the Shulgins, taking the next steps they envisioned:
transformpress.com
Last edited:
